A large number of drug-induced long QT syndromes are ascribed to blockage of hERG potassium channels. The aim of this study was to construct novel computational models to predict compounds blocking ...
CHAMPAIGN, Ill. -- Scientists have developed new drug compounds that thwart the pro-cancer activity of FOXM1, a transcription factor that regulates the activity of dozens of genes. The new compounds ...
Scientists have developed new drug compounds that thwart the pro-cancer activity of FOXM1, a transcription factor that regulates the activity of dozens of genes. The new compounds suppress tumor ...
(CN) — Attacking recurrent prostate cancer may now be easier after researchers discovered a compound that appears to stunt the disease's growth. In a study published Monday in the journal Nature ...